Epstein-Barr viral latent and early antigen serology in nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC) is cancer of the nasopharynx in humans. It is an insidious and often rapidly fatal disease that is rare worldwide, but is very common among the Chinese from southern China and south-east Asia. It is difficult to detect since, in its early stages, patients are asymptoma...

Full description

Saved in:
Bibliographic Details
Main Author: Tan, Timothy Ter Ming.
Other Authors: Gan-Yap, Yik Yuen
Format: Theses and Dissertations
Language:English
Published: 2008
Subjects:
Online Access:http://hdl.handle.net/10356/14073
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
Description
Summary:Nasopharyngeal carcinoma (NPC) is cancer of the nasopharynx in humans. It is an insidious and often rapidly fatal disease that is rare worldwide, but is very common among the Chinese from southern China and south-east Asia. It is difficult to detect since, in its early stages, patients are asymptomatic. However, NPC detected in its early stages is highly curable through radiation therapy. Clinically, it can be detected by an experienced medical practitioner using fibreoptic endoscopy, computer-assisted tomography or through serological tests. Serological testing detects the presence of specific antibodies to the Epstein-Barr virus, which is a crucial aetiological factor in the pathogenesis of the disease. Current methods include detection by indirect immunofluorescence assay which is laborious, subjective and requires highly-trained personnel, and enzyme-linked immunosorbent assay (ELISA), which can be easily performed by any hospital laboratory.